Effectiveness and safety of three years of bulevirtide monotherapy in patients with HDV-related compensated cirrhosis: the Italian compassionate use program

Digestive and Liver Disease · Elsevier

Аннотация

Publication date: December 2026 Source: Digestive and Liver Disease, Volume 58, Issue 12 Author(s): Maria Paola Anolli, Elisabetta Degasperi, Gianpiero D’Offizi, Francesco De Maria, Alessia Rianda, Maurizia R. Brunetto, Barbara Coco, Gabriella Verucchi, Alessia Ciancio, Alessandra Mangia, Teresa A. Santantonio, Nicola Coppola, Adriano Pellicelli, Mauro Viganò, Alessandro Loglio, Alessandro Federico, Francesca Pileri, Monia Maracci, Matteo Tonnini, Massimo Puoti

Читать у издателя →

Похожие статьи